Efficacy and Safety of a Novel Hemostatic Peptide Solution During Endoscopic Submucosal Dissection: A Multicenter Randomized Controlled Trial

To compare the effectiveness of the novel hemostatic peptide, TDM-621, with that of conventional hemostatic methods in treating intraoperative blood oozing during endoscopic submucosal dissection (ESD). METHODS: This multicenter, open-label, randomized controlled trial involved 227 patients with gas...

Descripción completa

Detalles Bibliográficos
Autores principales: Uraoka, Toshio, Uedo, Noriya, Oyama, Tsuneo, Saito, Yutaka, Yahagi, Naohisa, Fujimoto, Ai, Kawahara, Yoshiro, Mabe, Katsuhiro, Hikichi, Takuto, Yamamoto, Yorimasa, Tajiri, Hisao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889198/
https://www.ncbi.nlm.nih.gov/pubmed/36449784
http://dx.doi.org/10.14309/ajg.0000000000002060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889198/
https://www.ncbi.nlm.nih.gov/pubmed/36449784
http://dx.doi.org/10.14309/ajg.0000000000002060

Ejemplares similares